InsidersTradesSigma
Discover the detailed record of transactions filed by PRESTRELSKI STEVEN. Director active across 2 companies, notably Xeris Biopharma Holdings, Inc.. Aggregated, 7 filings have been logged. The latest transaction was disclosed on 22 February 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
7 of 7 declarations
Steven Prestrelski is a director at Xeris Biopharma Holdings, Inc. and Xeris Pharmaceuticals INC.
